Sprinter Health, a health-tech startup that delivers in-home diagnostic and care services, has announced the successful completion of its Series B funding round. The financing was led by leading venture capital firm General Catalyst, and included investments from Andreessen Horowitz, Google Ventures, Accel, and the Regents of the University of California.
Founded with the mission to make healthcare more accessible and personalized, Sprinter Health utilizes technology and trained healthcare professionals to provide lab draws, vitals checks, COVID-19 testing, and other diagnostic services in the comfort of patients’ homes. The company’s services aim to reduce friction for patients who might otherwise face challenges visiting clinics or hospitals, including the elderly, disabled, or those with mobility issues.
The new funding will be directed toward expanding Sprinter Health’s geographical reach, improving its technology platform, and scaling its medical staff to meet growing demand. As healthcare increasingly shifts toward patient-centered models and value-based care, the funding reflects increasing investor confidence in hybrid and home-based care models.
Sprinter Health’s approach harnesses real-time data collection and scheduling algorithms to efficiently dispatch healthcare professionals, known as “Sprinters,” to patients’ homes. The company typically partners with insurers, health systems, and digital health companies to integrate its services within broader care plans.
The participation of prominent venture capital firms underscores continued momentum in the home healthcare space, which has seen rapid growth accelerated by the COVID-19 pandemic and sustained by shifts in consumer expectations around convenience and safety.
With this Series B funding, Sprinter Health is well-positioned to address gaps in access to at-home medical services and to redefine how preventive and diagnostic care is delivered in the United States.
Source: https:// – Courtesy of the original publisher.
